Additional file 4 of Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

MLA

Bliss, Judith M., et al. Additional File 4 of Clinico-Pathologic Relationships with Ki67 and Its Change with Short-Term Aromatase Inhibitor Treatment in Primary ER + Breast Cancer: Further Results from the POETIC Trial (CRUK/07/015). Jan. 2023. EBSCOhost, https://doi.org/10.6084/m9.figshare.22619060.v1.

APA

Bliss, J. M., Tovey, H., Evans, A., Holcombe, C., Horgan, K., Mallon, E., Vidya, R., Skene, A., Dodson, A., Hills, M., Detre, S., Zabaglo, L., Banerji, J., Kilburn, L., Morden, J. P., Robertson, J. F. R., Smith, I., & Dowsett, M. (2023). Additional file 4 of Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015). https://doi.org/10.6084/m9.figshare.22619060.v1

Chicago

Bliss, Judith M., Holly Tovey, Abigail Evans, Chris Holcombe, Kieran Horgan, Elizabeth Mallon, Raghavan Vidya, et al. 2023. “Additional File 4 of Clinico-Pathologic Relationships with Ki67 and Its Change with Short-Term Aromatase Inhibitor Treatment in Primary ER + Breast Cancer: Further Results from the POETIC Trial (CRUK/07/015),” January. doi:10.6084/m9.figshare.22619060.v1.